1
|
Moreau MM, Pietropaolo S, Ezan J, Robert BJA, Miraux S, Maître M, Cho Y, Crusio WE, Montcouquiol M, Sans N. Scribble Controls Social Motivation Behavior through the Regulation of the ERK/Mnk1 Pathway. Cells 2022; 11:cells11101601. [PMID: 35626639 PMCID: PMC9139383 DOI: 10.3390/cells11101601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 05/06/2022] [Accepted: 05/06/2022] [Indexed: 02/01/2023] Open
Abstract
Social behavior is a basic domain affected by several neurodevelopmental disorders, including ASD and a heterogeneous set of neuropsychiatric disorders. The SCRIB gene that codes for the polarity protein SCRIBBLE has been identified as a risk gene for spina bifida, the most common type of neural tube defect, found at high frequencies in autistic patients, as well as other congenital anomalies. The deletions and mutations of the 8q24.3 region encompassing SCRIB are also associated with multisyndromic and rare disorders. Nonetheless, the potential link between SCRIB and relevant social phenotypes has not been fully investigated. Hence, we show that Scribcrc/+ mice, carrying a mutated version of Scrib, displayed reduced social motivation behavior and social habituation, while other behavioral domains were unaltered. Social deficits were associated with the upregulation of ERK phosphorylation, together with increased c-Fos activity. Importantly, the social alterations were rescued by both direct and indirect pERK inhibition. These results support a link between polarity genes, social behaviors and hippocampal functionality and suggest a role for SCRIB in the etiopathology of neurodevelopmental disorders. Furthermore, our data demonstrate the crucial role of the MAPK/ERK signaling pathway in underlying social motivation behavior, thus supporting its relevance as a therapeutic target.
Collapse
Affiliation(s)
- Maïté M. Moreau
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, 33077 Bordeaux, France; (J.E.); (B.J.A.R.); (M.M.); (M.M.)
- Correspondence: (M.M.M.); (N.S.)
| | - Susanna Pietropaolo
- Univ. Bordeaux, CNRS, Aquitaine Institute for Cognitive and Integrative Neurosciences, UMR5287, 33405 Bordeaux, France; (S.P.); (Y.C.); (W.E.C.)
| | - Jérôme Ezan
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, 33077 Bordeaux, France; (J.E.); (B.J.A.R.); (M.M.); (M.M.)
| | - Benjamin J. A. Robert
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, 33077 Bordeaux, France; (J.E.); (B.J.A.R.); (M.M.); (M.M.)
| | - Sylvain Miraux
- Univ. Bordeaux, CNRS, Centre de Résonance Magnétique des Systèmes Biologiques UMR5536, 33077 Bordeaux, France;
| | - Marlène Maître
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, 33077 Bordeaux, France; (J.E.); (B.J.A.R.); (M.M.); (M.M.)
| | - Yoon Cho
- Univ. Bordeaux, CNRS, Aquitaine Institute for Cognitive and Integrative Neurosciences, UMR5287, 33405 Bordeaux, France; (S.P.); (Y.C.); (W.E.C.)
| | - Wim E. Crusio
- Univ. Bordeaux, CNRS, Aquitaine Institute for Cognitive and Integrative Neurosciences, UMR5287, 33405 Bordeaux, France; (S.P.); (Y.C.); (W.E.C.)
| | - Mireille Montcouquiol
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, 33077 Bordeaux, France; (J.E.); (B.J.A.R.); (M.M.); (M.M.)
| | - Nathalie Sans
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, 33077 Bordeaux, France; (J.E.); (B.J.A.R.); (M.M.); (M.M.)
- Correspondence: (M.M.M.); (N.S.)
| |
Collapse
|
2
|
Palmier M, Maître M, Doat H, Morel C, Leste-Lasserre T, Boiziau C, Maurel D. Age-related changes in osteocytes and blood vessels in the compact bone of the femur in mouse. Bone Rep 2022. [DOI: 10.1016/j.bonr.2022.101354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
3
|
Oliveira da Cruz JF, Busquets-Garcia A, Zhao Z, Varilh M, Lavanco G, Bellocchio L, Robin L, Cannich A, Julio-Kalajzić F, Lesté-Lasserre T, Maître M, Drago F, Marsicano G, Soria-Gómez E. Specific Hippocampal Interneurons Shape Consolidation of Recognition Memory. Cell Rep 2021; 32:108046. [PMID: 32814049 PMCID: PMC7443618 DOI: 10.1016/j.celrep.2020.108046] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 06/15/2020] [Accepted: 07/27/2020] [Indexed: 12/27/2022] Open
Abstract
A complex array of inhibitory interneurons tightly controls hippocampal activity, but how such diversity specifically affects memory processes is not well understood. We find that a small subclass of type 1 cannabinoid receptor (CB1R)-expressing hippocampal interneurons determines episodic-like memory consolidation by linking dopamine D1 receptor (D1R) signaling to GABAergic transmission. Mice lacking CB1Rs in D1-positive cells (D1-CB1-KO) display impairment in long-term, but not short-term, novel object recognition memory (NOR). Re-expression of CB1Rs in hippocampal D1R-positive cells rescues this NOR deficit. Learning induces an enhancement of in vivo hippocampal long-term potentiation (LTP), which is absent in mutant mice. CB1R-mediated NOR and the associated LTP facilitation involve local control of GABAergic inhibition in a D1-dependent manner. This study reveals that hippocampal CB1R-/D1R-expressing interneurons control NOR memory, identifying a mechanism linking the diversity of hippocampal interneurons to specific behavioral outcomes. CB1Rs are present in hippocampal D1R-positive interneurons CB1R/D1R-positive interneurons control the late phase of recognition memory CB1R/D1R-positive interneurons control learning-induced facilitation of LTP
Collapse
Affiliation(s)
- Jose F Oliveira da Cruz
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France; New York University, Center for Neural Science, New York, NY 10003, USA
| | - Arnau Busquets-Garcia
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France; Integrative Pharmacology and System Neuroscience, IMIM-Hospital del Mar Medical Research Institute, Barcelona 08003, Spain
| | - Zhe Zhao
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France
| | - Marjorie Varilh
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France
| | - Gianluca Lavanco
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania 95124, Italy
| | - Luigi Bellocchio
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France
| | - Laurie Robin
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France
| | - Astrid Cannich
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France
| | - Francisca Julio-Kalajzić
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France
| | - Thierry Lesté-Lasserre
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France
| | - Marlène Maître
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France
| | - Filippo Drago
- Integrative Pharmacology and System Neuroscience, IMIM-Hospital del Mar Medical Research Institute, Barcelona 08003, Spain
| | - Giovanni Marsicano
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France.
| | - Edgar Soria-Gómez
- INSERM U1215, NeuroCentre Magendie, Bordeaux 33300, France; University of Bordeaux, Bordeaux 33300, France; Ikerbasque-Basque Foundation for Science, Bilbao 48013, Spain; Department of Neuroscience, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU) Leioa 48940, Spain; Achucarro Basque Center for Neuroscience, Leioa 48940, Spain.
| |
Collapse
|
4
|
Kerloch T, Farrugia F, Bouit L, Maître M, Terral G, Koehl M, Mortessagne P, Heng JIT, Blanchard M, Doat H, Leste-Lasserre T, Goron A, Gonzales D, Perrais D, Guillemot F, Abrous DN, Pacary E. The atypical Rho GTPase Rnd2 is critical for dentate granule neuron development and anxiety-like behavior during adult but not neonatal neurogenesis. Mol Psychiatry 2021; 26:7280-7295. [PMID: 34561615 PMCID: PMC8872985 DOI: 10.1038/s41380-021-01301-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 09/06/2021] [Accepted: 09/08/2021] [Indexed: 02/08/2023]
Abstract
Despite the central role of Rho GTPases in neuronal development, their functions in adult hippocampal neurogenesis remain poorly explored. Here, by using a retrovirus-based loss-of-function approach in vivo, we show that the atypical Rho GTPase Rnd2 is crucial for survival, positioning, somatodendritic morphogenesis, and functional maturation of adult-born dentate granule neurons. Interestingly, most of these functions are specific to granule neurons generated during adulthood since the deletion of Rnd2 in neonatally-born granule neurons only affects dendritogenesis. In addition, suppression of Rnd2 in adult-born dentate granule neurons increases anxiety-like behavior whereas its deletion in pups has no such effect, a finding supporting the adult neurogenesis hypothesis of anxiety disorders. Thus, our results are in line with the view that adult neurogenesis is not a simple continuation of earlier processes from development, and establish a causal relationship between Rnd2 expression and anxiety.
Collapse
Affiliation(s)
- Thomas Kerloch
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Fanny Farrugia
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Lou Bouit
- grid.462202.00000 0004 0382 7329Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, F-33000 Bordeaux, France
| | - Marlène Maître
- grid.412041.20000 0001 2106 639XLaser microdissection Facility, Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Geoffrey Terral
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Muriel Koehl
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Pierre Mortessagne
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Julian Ik-Tsen Heng
- grid.1032.00000 0004 0375 4078Curtin Health Innovation Research Institute, Curtin University, 6102 Bentley, WA Australia
| | - Mylène Blanchard
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Hélène Doat
- grid.412041.20000 0001 2106 639XLaser microdissection Facility, Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France ,grid.412041.20000 0001 2106 639XTranscriptome Facility, Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Thierry Leste-Lasserre
- grid.412041.20000 0001 2106 639XTranscriptome Facility, Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Adeline Goron
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Delphine Gonzales
- grid.412041.20000 0001 2106 639XGenotyping Facility, Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - David Perrais
- grid.462202.00000 0004 0382 7329Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, F-33000 Bordeaux, France
| | - François Guillemot
- grid.451388.30000 0004 1795 1830The Francis Crick Institute, 1 Midland Road, London, NW1 1AT UK
| | - Djoher Nora Abrous
- grid.412041.20000 0001 2106 639XUniv. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France
| | - Emilie Pacary
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300, Bordeaux, France.
| |
Collapse
|
5
|
Blaszczyk L, Maître M, Lesté-Lasserre T, Clark S, Cota D, Oliet SHR, Fénelon VS. Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation. J Neuroinflammation 2018; 15:349. [PMID: 30572902 PMCID: PMC6302506 DOI: 10.1186/s12974-018-1378-z] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2018] [Accepted: 11/26/2018] [Indexed: 12/28/2022] Open
Abstract
Background Spinal reactive astrocytes and microglia are known to participate to the initiation and maintenance of neuropathic pain. However, whether reactive astrocytes and microglia in thalamic nuclei that process sensory-discriminative aspects of pain play a role in pain behavior remains poorly investigated. Therefore, the present study evaluated whether the presence of reactive glia (hypertrophy, increased number and upregulation of glial markers) in the ventral posterolateral thalamic nucleus (VPL) correlates with pain symptoms, 14 and 28 days after unilateral L5/L6 spinal nerve ligation (SNL) in rats. Methods Mechanical allodynia and hyperalgesia (von Frey filament stimulation) as well as ambulatory pain (dynamic weight bearing apparatus) were assessed. Levels of nine glial transcripts were determined by quantitative real-time PCR on laser microdissected thalamic nuclei, and levels of proteins were assessed by Western blot. We also studied by immunohistofluorescence the expression of glial markers that label processes (GFAP for astrocytes and iba-1 for microglia) and cell body (S100β for astrocytes and iba-1 for microglia) and quantified the immunostained surface and the number of astrocytes and microglia (conventional counts and optical dissector method of stereological counting). Results Differential, time-dependent responses were observed concerning microglia and astrocytes. Specifically, at day 14, iba-1 immunostained area and number of iba-1 immunopositive cells were decreased in the VPL of SNL as compared to naïve rats. By contrast, at day 28, GFAP-immunostained area was increased in the VPL of SNL as compared to naïve rats while number of GFAP/S100β immunopositive cells remained unchanged. Using quantitative real-time PCR of laser microdissected VPL, we found a sequential increase in mRNA expression of cathepsin S (day 14), fractalkine (day 28), and fractalkine receptor (day 14), three well-known markers of microglial reactivity. Using Western blot, we confirmed an increase in protein expression of fractalkine receptor at day 14. Conclusions Our results demonstrate a sequential alteration of microglia and astrocytes in the thalamus of animals with lesioned peripheral nerves. Furthermore, our data report unprecedented concomitant molecular signs of microglial activation and morphological signs of microglial decline in the thalamus of these animals.
Collapse
Affiliation(s)
- Lucie Blaszczyk
- Bordeaux University, Bordeaux, France.,Neurocentre Magendie, INSERM U1215, Bordeaux, France
| | - Marlène Maître
- Bordeaux University, Bordeaux, France.,Neurocentre Magendie, INSERM U1215, Bordeaux, France
| | - Thierry Lesté-Lasserre
- Bordeaux University, Bordeaux, France.,Neurocentre Magendie, INSERM U1215, Bordeaux, France
| | - Samantha Clark
- Bordeaux University, Bordeaux, France.,Neurocentre Magendie, INSERM U1215, Bordeaux, France
| | - Daniela Cota
- Bordeaux University, Bordeaux, France.,Neurocentre Magendie, INSERM U1215, Bordeaux, France
| | - Stéphane H R Oliet
- Bordeaux University, Bordeaux, France.,Neurocentre Magendie, INSERM U1215, Bordeaux, France
| | - Valérie S Fénelon
- Bordeaux University, Bordeaux, France. .,Neurocentre Magendie, INSERM U1215, Bordeaux, France.
| |
Collapse
|
6
|
Schneider T, Andronopoulos S, Camps J, Duranova T, Gallego E, Gering F, Isnard O, Maître M, Murith C, Oughton D, Raskob W. The work programme of NERIS in post-accident recovery. Ann ICRP 2018; 47:221-228. [PMID: 29652175 DOI: 10.1177/0146645318756291] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
NERIS is the European platform on preparedness for nuclear and radiological emergency response and recovery. Created in 2010 with 57 organisations from 28 different countries, the objectives of the platform are to: improve the effectiveness and coherency of current approaches to preparedness; identify further development needs; improve 'know how' and technical expertise; and establish a forum for dialogue and methodological development. The NERIS Strategic Research Agenda is now structured with three main challenges: (i) radiological impact assessments during all phases of nuclear and radiological events; (ii) countermeasures and countermeasure strategies in emergency and recovery, decision support, and disaster informatics; and (iii) setting up a multi-faceted framework for preparedness for emergency response and recovery. The Fukushima accident has highlighted some key issues for further consideration in NERIS research activities, including: the importance of transparency of decision-making processes at local, regional, and national levels; the key role of access to environmental monitoring; the importance of dealing with uncertainties in assessment and management of the different phases of the accident; the use of modern social media in the exchange of information; the role of stakeholder involvement processes in both emergency and recovery situations; considerations of societal, ethical, and economic aspects; and the reinforcement of education and training for various actors. This paper emphasises the main issues at stake for NERIS for post-accident management.
Collapse
Affiliation(s)
- T Schneider
- a Nuclear Evaluation Protection Centre, CEPN, 28 rue de la Redoute, 92260 Fontenay-aux-Roses, France
| | - S Andronopoulos
- b National Centre for Scientific Research "Demokritos", Greece
| | - J Camps
- c Belgian Nuclear Research Centre, Belgium
| | | | - E Gallego
- e Polytechnical University of Madrid, Spain
| | - F Gering
- f Federal Office for Radiation Protection, Germany
| | - O Isnard
- g Institute for Radiation Protection and Nuclear Safety, France
| | - M Maître
- a Nuclear Evaluation Protection Centre, CEPN, 28 rue de la Redoute, 92260 Fontenay-aux-Roses, France
| | - C Murith
- h Federal Office for Public Health, Switzerland
| | - D Oughton
- i Norwegian University of Life Science, Norway
| | - W Raskob
- j Karlsruhe Institute of Technology, Germany
| |
Collapse
|
7
|
Cazzaniga M, Rico F, Fernández Pineda L, González C, Quero M, Maître M. [Contribution of color Doppler in the diagnosis of bilateral ductus arteriosus]. Rev Esp Cardiol 1998; 51:332-5. [PMID: 9608806 DOI: 10.1016/s0300-8932(98)74752-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
We report a neonate with distal bilateral ductus arteriosus origin of nonconfluent pulmonary arteries which was only diagnosed accurately by 2-D echo Doppler color flow mapping in the context of situs ambiguous, univentricular A-V connection and pulmonary atresia with normal systemic/pulmonary venous drainage. The color flow appearance of this singular vascular anatomy was enhanced after prostaglandin administration, which, allowed us to see an image resembling a "moustache morphology". At 36 months of age, and after a successful bilateral 4 mm modified Blalock Taussig shunt implantation by sequential approach, the patient is waiting for the next surgical step which will include a restoration of the confluence of the pulmonary arteries with bidirectional Glenn operation. Brief embryological and differential diagnosis comments are discussed.
Collapse
Affiliation(s)
- M Cazzaniga
- Laboratorio de Ecocardiografía, Servicio de Cardiología Pediátrica, Hospital Ramón y Cajal, Madrid
| | | | | | | | | | | |
Collapse
|
8
|
Cazzaniga M, Fernández Pineda L, Abraira V, Quero MC, Herraiz I, Maître M, Bermúdez R, Quero M. [Clinical and echocardiographic impact of neonatal aortic valvuloplasty]. Rev Esp Cardiol 1998; 51:141-51. [PMID: 9542437 DOI: 10.1016/s0300-8932(98)74724-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVES The selection of patients for balloon aortic valvuloplasty is a vital clinical challenge in neonatal aortic stenosis. The present study was designed to establish possible predicting factors for poor results after balloon therapy. PATIENTS AND METHODS 2D echocardiographic, Doppler color and clinical variables (grade of cardiac failure, aortic "anulus", mitral anulus, left ventricular diameter, ascending aorta, instantaneous Doppler gradient, and grade of aortic regurgitation) were analyzed in 32 neonates submitted to balloon dilation at 22 +/- 18 days of life. The evaluations were conducted during three periods in respect to balloon therapy (A: before; B: immediately after, and C: mid-term follow-up). The outcome in both, B and C periods was defined as favorable (all survivors with Doppler gradient < or = 70 mmHg and no other intervention on the valve) and unfavorable (death, first stage of univentricularization, valvular replacement or survivors with Doppler gradient > 70 mmHg). Mean values between subgroups were compared by Wilcoxon test; unconditional logistic regression was used to analyze the impact of cardiac failure and anatomic variables (continuous, categorized or Z) on the outcome. RESULTS The Doppler gradient decreased from 70 +/- 28 to 34 +/- 14 mmHg after the valvuloplasty, and no changes were detected in the follow-up period (36 +/- 8 mmHg). An immediate favorable result was obtained in 72% of the patients; its consisted of 50% in period C. Nine neonates had an immediate unfavorable outcome (6 deaths and 3 with Norwood operation). In the follow-up, three patients had valvular replacement, one patient Doppler gradient > 70 mmHg and one patient with left ventricular endomyocardial abnormalities died. The severe cardiac failure (odds ratio: 33; CL 2.4-443; p = 0.008) and all categorized anatomic variables (aortic "anulus" < or = 6 mm; mitral anulus < or = 9 mm; ascending aorta < or = 8 mm; left ventricular diameter < or = 13 mm) were related with the immediate poor outcome. At 7.6 years, survival and freedom with no valvular replacement nor reintervention probability rates were 83% and 67%, respectively. CONCLUSIONS 2D echo Doppler provides essential information about the anatomic and functional lesions coexisting with severe or critical aortic stenosis in neonates. Patients with left heart hypoplasia and severe heart failure should not be candidates for balloon valvuloplasty. The degree of residual aortic regurgitation and endomyocardial abnormalities of the left ventricle play an important role in the mid-term follow-up.
Collapse
Affiliation(s)
- M Cazzaniga
- Servicio de Cardiología Pediátrica, Hospital Ramón y Cajal, Madrid
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Richard F, Sanne JL, Bourde O, Weissman D, Ehret M, Cash C, Maître M, Pujol JF. Variation of tryptophan-5-hydroxylase concentration in the rat raphe dorsalis nucleus after p-chlorophenylalanine administration. I. A model to study the turnover of the enzymatic protein. Brain Res 1990; 536:41-5. [PMID: 2150773 DOI: 10.1016/0006-8993(90)90006-w] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
An immunoblot procedure was developed to quantify the amount of tryptophan hydroxylase (TpOH), the rate limiting enzyme in the synthesis of serotonin, in the rat raphe dorsalis nucleus (NRD). Using this method we have studied the time course variations in TpOH protein level after a single p-chlorophenylalanine (PCPA) i.p. injection (300 mg/kg). PCPA provoked a rapid and large decrease of TpOH in the NRD, without affecting neuron-specific enolase in the NRD or TpOH in the locus coeruleus. The decrease in TpOH was maximum (-60% of the control value) 2 days after the drug administration and followed a monoexponential law which allowed us to estimate the half-life of this enzymatic protein as 1.43 days and to postulate that, during these 2 days, TpOH synthesis was inhibited. The neosynthesis of TpOH molecules from 2 to 7 days was estimated to be 57.8 U TpOH/NRD/day which was comparable to the initial steady state of synthesis (48.44 U TpOH/NRD/day). In vivo administration of 6-fluorotryptophan or in vitro incubation of raphe homogenates with either halogenated derivative had no effect on TpOH protein levels. PCPA should be an interesting tool to study the turnover rate of TpOH protein.
Collapse
Affiliation(s)
- F Richard
- C.N.R.S. U.M.R. 105, Département de Physiologie, Faculté de Médecine Alexis Carrel, Lyon, France
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Weissmann D, Chamba G, Debure L, Rousset C, Richard F, Maître M, Pujol JF. Variation of tryptophan-5-hydroxylase concentration in the rat raphe dorsalis nucleus after p-chlorophenylalanine administration. II. Anatomical distribution of the tryptophan-5-hydroxylase protein and regional variation of its turnover rate. Brain Res 1990; 536:46-55. [PMID: 2150774 DOI: 10.1016/0006-8993(90)90007-x] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Distribution of tryptophan-5-hydroxylase (TpOH)-containing cells and TpOH protein tissue concentrations were evaluated in the nucleus raphe dorsalis (NRD) of rat brain by immunocytochemistry and direct transfer onto nitrocellulose filters of unfixed adjacent brain sections. This work has demonstrated that: (1) the direct transfer onto nitrocellulose filters could be easily used for the quantitative analysis of TpOH protein distribution; (2) the origin of the TpOH in this brain nucleus was preferentially cellular; (3) classical subdivisions, qualitatively defined from morphometric and topographic observations could be precisely described in terms of cellular density, tissue and cellular concentrations and turnover of TpOH protein. Such differences could imply a physiological control of TpOH gene expression in the serotoninergic neurons.
Collapse
Affiliation(s)
- D Weissmann
- Laboratoire de Neuropharmacologie Moléculaire, C.N.R.S. U.M.R. 105, C.E.R.M.E.P. 59, Lyon, France
| | | | | | | | | | | | | |
Collapse
|
11
|
Belin MF, Weisman-Nanopoulos D, Steinbusch H, Verhofstad A, Maître M, Jouvet M, Pujol JF. [Demonstration of glutamate decarboxylase and serotonin in the same neuron of the nucleus raphe dorsalis of the rat by the methods of immunocytochemical doubling labelling]. C R Seances Acad Sci III 1981; 293:337-41. [PMID: 6797685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
12
|
Blindermann JM, Maître M, Ossola L, Mandel P. [Purification of the glutamate decarboxylase from human brain]. C R Acad Hebd Seances Acad Sci D 1977; 285:1079-82. [PMID: 23221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
A method of purifying the glutamate decarboxylase from human brain is described. The enzyme was purified 8 000 fold in regard to the initial homogenate and appears homogenous by electrophoresis, both in denaturing and non-denaturing conditions. The molecular weight of the native enzyme and its subunits indicate that GAD from human brain is formed by two similar if non identical polypeptide chains. The Km for glutamate and pyridoxal phosphate found for the human enzyme, respectively 1,2.10(-3) M and 0,13.10(-6) M, are close to the Km found for the Mouse enzyme.
Collapse
|
13
|
Maître M, Ciesielski L, Cash C, Mandel P. Purification and studies on some properties of the 4-aminobutyrate : 2-oxoglutarate transaminase from rat brain. Eur J Biochem 1975; 52:157-69. [PMID: 1164912 DOI: 10.1111/j.1432-1033.1975.tb03983.x] [Citation(s) in RCA: 65] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Using various chromatographic procedures, 4-aminobutyrate : 2-oxoglutarate transaminase from rat brain has been purified 2400 times with respect to the initial brain homogenate. The purified protein, which has a specific activity of 10 mumol times min -1, x mg-1 gave a single band by acrylamide gel electrophoresis and isoelectric focusing. It has a molecular weight of 105000 +/- 5000 and an isoelectric point of 6.8. In the presence of 0.1% sodium dodecylsulphate, a single protein band is seen on polyacrylamide gel, corresponding to a molecular weight of 57000 +/- 5000. N-terminal analysis reveals two chains with the same N-terminal amino acid, thus the enzyme may be considered as a dimer consisting of two identical subunits. The pH optimum for enzyme activity is 8.5. Studies of the enzymic reaction show that the general mechanism is of the ping-pong bi-bi model. The Km for 2-oxoglutarate at saturating 4-aminobutyrate extrapolated to saturating 2-oxoglutarate concentration is 4 mM. 2-Oxoglutarate competitively inhibits the enzyme with respect to 4-aminobutyrate, with a Ki of 1.8 times 10(-4) M. The same phenomenon is seen for the reverse reaction where the Ki is 6.6 times 10(-4) M for succinic semi-aldehyde.
Collapse
|